Home/Third Pole Therapeutics/Elizabeth Holmberg

EH

Elizabeth Holmberg

Chief Financial Officer

Third Pole Therapeutics

Therapeutic Areas

Respiratory Critical Care

Third Pole Therapeutics Pipeline

Drug	Indication	Phase
eNOfit Portable Inhaled Nitric Oxide Delivery System	Respiratory failure / Pulmonary Hypertension (assumed, based on iNO use)	Feasibility

Leadership Team at Third Pole Therapeutics

Chief Executive Officer

View full Third Pole Therapeutics profile